Decision Support Tool for Atrial Fibrillation

Recruiting in Palo Alto (17 mi)

Overseen byLarry Jackson

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Duke University

No Placebo Group

Trial Summary

What is the purpose of this trial?

The study is a pilot analysis using a decision on the risk and benefits of oral anticoagulation for stroke reduction for patients with non-valvular atrial fibrillation. This study is a feasibility and acceptability analysis but will also measure preliminary effectiveness measures. The investigator hypothesizes that a patient decision support tool will increase decision quality and secondarily increase the use of oral anticoagulation in Black patients with non-valvular atrial fibrillation.

Research Team

Larry Jackson

Principal Investigator

Duke University

Eligibility Criteria

This trial is for Black and White adults over 18 with non-valvular atrial fibrillation (NVAF) who have a CHA2DS2-VASc score of at least 2, indicating a higher risk of stroke. They must be new patients at primary care or cardiology clinics considering starting oral anticoagulation but cannot participate if they can't speak English or provide informed consent.

Inclusion Criteria

I am starting oral anticoagulation treatment at a primary care or cardiology clinic.

I have been diagnosed with non-valvular atrial fibrillation.

I am an adult aged 18 or older.

See 1 more

Exclusion Criteria

I am unable to understand or sign the consent form.

Unable to speak English

Treatment Details

Interventions

Patient Decision Support Tool (Behavioural Intervention)

Trial OverviewThe study tests whether a patient decision support tool can improve the quality of decisions made by patients regarding the use of oral anticoagulants to prevent strokes in NVAF. It aims to see if this tool helps, especially among Black patients, and will assess its feasibility and acceptability.

Participant Groups

2Treatment groups

Experimental Treatment

Active Control

Group I: Patient Decision Support ToolExperimental Treatment1 Intervention

Patient decision support tool to be used in conjunction with physician counseling to discuss the risk and benefits of systemic oral anticoagulation.

Group II: Usual Healthcare CounselingActive Control1 Intervention

Traditional physician counseling regarding the risk and benefits of systemic oral anticoagulation